Login to Your Account



ImClone, BMS File New BLA Seeking Approval Of Erbitux

By Kim Coghill


Friday, August 15, 2003
Minus the Waksal brothers, ImClone Systems Inc. and Bristol-Myers Squibb Co. forged ahead and, as planned, filed a biologics license application for the investigational IgG1 monoclonal antibody Erbitux for metastatic colorectal cancer. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription